Duopharma Biotech Bhd (XKLS:7148) COGS-to-Revenue : 0.64 (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd COGS-to-Revenue?

Duopharma Biotech Bhd's Cost of Goods Sold for the three months ended in Mar. 2025 was RM169.4 Mil. Its Revenue for the three months ended in Mar. 2025 was RM262.7 Mil.

Duopharma Biotech Bhd's COGS to Revenue for the three months ended in Mar. 2025 was 0.64.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Duopharma Biotech Bhd's Gross Margin % for the three months ended in Mar. 2025 was 35.51%.

Duopharma Biotech Bhd COGS-to-Revenue Historical Data

The historical data trend for Duopharma Biotech Bhd's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd COGS-to-Revenue Chart

Duopharma Biotech Bhd Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.60

0.62

0.63

Duopharma Biotech Bhd Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.62	0.66	0.63	0.61	0.64

Duopharma Biotech Bhd COGS-to-Revenue Calculation

Duopharma Biotech Bhd's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	512.157	/	813.695
	=	0.63

Duopharma Biotech Bhd's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	169.449	/	262.738
	=	0.64

Duopharma Biotech Bhd (XKLS:7148) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Duopharma Biotech Bhd's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	169.449 / 262.738
	=	35.51 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Duopharma Biotech Bhd COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.

Duopharma Biotech Bhd Headlines

No Headlines